Pacira BioSciences (PCRX)
(Real Time Quote from BATS)
$20.18 USD
+0.81 (4.18%)
Updated Jul 22, 2024 03:54 PM ET
After-Market: $20.39 +0.21 (1.04%) 4:16 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.18 USD
+0.81 (4.18%)
Updated Jul 22, 2024 03:54 PM ET
After-Market: $20.39 +0.21 (1.04%) 4:16 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
Zacks News
What's in Store for ImmunoGen (IMGN) this Earnings Season?
by Zacks Equity Research
ImmunoGen, Inc. (IMGN) is scheduled to report results for the three months ended Dec 31, 2016 on Feb 17, before the opening bell. Overall, the company has posted an average negative surprise of 19.34%.
Will Zoetis (ZTS) Disappoint Estimates This Earnings Season?
by Zacks Equity Research
Zoetis Inc. (ZTS) is scheduled to report fourth-quarter and full year 2016 results on Feb 16 before the market opens.